Developmental Centers for Translational Research on the Clinical Neurobiology of Drug Addiction
The summary for the Developmental Centers for Translational Research on the Clinical Neurobiology of Drug Addiction grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Developmental Centers for Translational Research on the Clinical Neurobiology of Drug Addiction: The National Institute on Drug Abuse (NIDA) invites applications to support the development of translational research centers on the neurobiology of drug abuse that have a strong clinical/human neurobiology focus and the capability to integrate preclinical/animal studies that will serve to directly inform the direction of the clinical research. Advances in the technological armamentarium that can now be brought to bear on questions concerning the acute and chronic effects of drugs of abuse, the factors that influence addiction liability, the neurobiological alterations that may lead to abuse and addiction, and the effects of intrinsic and extrinsic influences on the course of treatment and relapse now make it possible to pose very specific questions on the nature of drug effects in the human nervous system. Despite technical advances, however, the spectrum of approaches that can be used in preclinical investigations renders animal research much more suitable for mechanistic studies of the neurobiology of drug abuse. This funding opportunity announcement is designed to encourage teams of investigators to propose the development of research programs with a primary focus on clearly defined issues in drug abuse and addiction in clinical populations that can simultaneously be investigated in animal models with the aim of, ultimately, using the preclinical findings to refine and direct the clinical research. It is expected that the centers funded through this RFA will be well positioned to compete for funding through a subsequent funding opportunity announcement for larger centers for Translational Research on Drug Addiction.
Federal Grant Title: | Developmental Centers for Translational Research on the Clinical Neurobiology of Drug Addiction |
Federal Agency Name: | National Institutes of Health |
Grant Categories: | Health Education |
Type of Opportunity: | Discretionary |
Funding Opportunity Number: | RFA-DA-05-003 |
Type of Funding: | Grant |
CFDA Numbers: | 93.279 |
CFDA Descriptions: | Drug Abuse Research Programs |
Current Application Deadline: | No deadline provided |
Original Application Deadline: | Nov 17, 2004 |
Posted Date: | May 03, 2004 |
Creation Date: | May 03, 2004 |
Archive Date: | Dec 17, 2004 |
Total Program Funding: | |
Maximum Federal Grant Award: | $500,000 |
Minimum Federal Grant Award: | |
Expected Number of Awards: | |
Cost Sharing or Matching: | No |
- Applicants Eligible for this Grant
- State governments County governments City or township governments Special district governments Independent school districts Public and State controlled institutions of higher education Native American tribal governments (Federally recognized) Public housing authorities/Indian housing authorities Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education For profit organizations other than small businesses Small businesses
- Link to Full Grant Announcement
- Information not provided
- Grant Announcement Contact
- If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [email protected] NIH OER Webmaster
- Similar Government Grants
- • Research on the Neuro-Immune Axis in the context of HIV and Substance Use (R01 Clinical Tr...
- • Research on the Neuro-Immune Axis in the Context of HIV and Substance Use (R21 Clinical Tr...
- • Developing Digital Therapeutics for Substance Use Disorders (UG3/UH3 Clinical Trial option...
- • Transformative Research on the Basic Mechanisms of Polysubstance use in Addiction (R01 - C...
- • Mechanistic Studies on Social Behavior in Substance Use Disorder (R01 Clinical Trials Not ...
- • NIDA Phase II Small Business Innovation Research (SBIR [R44]) Competing Renewal Awards
- • Drug Abuse Aspects of Hiv/Aids and Other Infections
- • Epidemiology of Drug Abuse
- More Grants from the National Institutes of Health
- • HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allow...
- • Technologies and Assays for Therapeutic Genome Editing INDs (U01, Clinical Trial Not Allow...
- • Developmental AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optio...
- • AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional)
- • NIH Directors Pioneer Award Program (DP1 Clinical Trial Optional)